None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-BOOST	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
DOSE-BOOST	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
DOSE-BOOST	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-DOSE	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-DOSE	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 (
None	of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions
None	50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25
None	fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions
None	<RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
DOSE-DOSE	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions
None	hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
DOSE-DOSE	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> )
None	chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
DOSE-DOSE	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on
None	cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
DOSE-DOSE	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with
None	then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
DOSE-DOSE	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
DOSE-DOSE	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions
None	<RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
DOSE-DOSE	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice
None	<RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
DOSE-DOSE	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation
None	a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
DOSE-DOSE	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> (
None	) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
DOSE-DOSE	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads
None	days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-DOSE	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-DOSE	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose :
None	, with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
DOSE-DOSE	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
DOSE-DOSE	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5
None	final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
DOSE-DOSE	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
DOSE-DOSE	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1
None	<RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
DOSE-DOSE	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5
None	consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
DOSE-DOSE	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions
None	therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
DOSE-DOSE	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over
None	whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
DOSE-DOSE	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al .
None	7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
DOSE-DOSE	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
DOSE-DOSE	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to
None	for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
DOSE-DOSE	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
DOSE-DOSE	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> )
None	rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
DOSE-DOSE	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
DOSE-DOSE	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 ,
None	5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
DOSE-DOSE	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64
None	<RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
DOSE-DOSE	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
DOSE-DOSE	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions ,
None	, including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
DOSE-DOSE	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for
None	boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of
None	35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25
None	<RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
DOSE-DOSE	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45
None	1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
DOSE-DOSE	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200
None	to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once
None	fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
DOSE-DOSE	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END>
None	x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
DOSE-DOSE	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of
None	64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
DOSE-DOSE	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
DOSE-DOSE	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
DOSE-DOSE	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66
None	Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
DOSE-DOSE	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day
None	fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
DOSE-DOSE	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ;
None	Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
DOSE-DOSE	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x
None	start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
DOSE-DOSE	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total
None	fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
DOSE-DOSE	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to
None	fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total
None	: <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
DOSE-DOSE	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to
None	4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
DOSE-DOSE	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given
None	of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
DOSE-DOSE	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
DOSE-DOSE	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
DOSE-DOSE	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
DOSE-DOSE	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
DOSE-DOSE	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole
None	x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
DOSE-DOSE	x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV
None	<RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
DOSE-DOSE	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
DOSE-DOSE	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
DOSE-DOSE	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
DOSE-DOSE	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
DOSE-DOSE	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
DOSE-DOSE	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
DOSE-DOSE	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	, 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
DOSE-DOSE	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting
None	was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in
None	in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
DOSE-DOSE	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions
None	, PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
DOSE-DOSE	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ;
None	and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total
None	<RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors
None	margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
DOSE-DOSE	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
DOSE-DOSE	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	, for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
DOSE-DOSE	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given
None	total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
DOSE-DOSE	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation
None	<RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
DOSE-DOSE	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of
None	<RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
DOSE-DOSE	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END>
None	involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total
None	on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8
None	to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after
None	to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician
None	<RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day
None	10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
DOSE-DOSE	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END>
None	4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
DOSE-DOSE	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day
None	specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days
None	to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
DOSE-DOSE	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
DOSE-DOSE	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	<RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
DOSE-DOSE	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
DOSE-DOSE	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END>
None	total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times
None	dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
DOSE-DOSE	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END>
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 (
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
DOSE-FXFREQ	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions
DOSE-FXFREQ	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	50.4 Gy over 6 weeks in 1.5-Gy fractions <FractionFrequency-START> twice per day <FractionFrequency-END> on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
DOSE-FXFREQ	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
DOSE-FXFREQ	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	a dose of 50 Gy with 150 cGy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
DOSE-FXFREQ	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
DOSE-FXFREQ	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1
None	1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 , 3 , 5
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
DOSE-FXFREQ	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
DOSE-FXFREQ	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 ,
DOSE-FXFREQ	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
DOSE-FXFREQ	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	35 fractions ( total dose : 60 to 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	60 to 70 Gy ) , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
DOSE-FXFREQ	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
DOSE-FXFREQ	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	1.5 Gy fractions x 16 fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	fractions , given <FractionFrequency-START> twice per day <FractionFrequency-END> ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
DOSE-FXFREQ	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	involved fields 58 to 66 Gy , given <FractionFrequency-START> 5 times per week <FractionFrequency-END> to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
DOSE-FXFREQ	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
DOSE-FXFREQ	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END>
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	1.8 to 2.0 Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	Gy <FractionFrequency-START> once per day <FractionFrequency-END> Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times
DOSE-FXFREQ	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy
DOSE-FXFREQ	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-FXFREQ	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-FXFREQ	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-FXFREQ	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-FXFREQ	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given <FractionFrequency-START> twice per day <FractionFrequency-END> , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , <FractionFrequency-START> 5 times per week <FractionFrequency-END> ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
DOSE-FXNO	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-FXNO	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-FXNO	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-FXNO	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6
None	given in <RT_Fraction_Number-START> 5 <RT_Fraction_Number-END> fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	1.8 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
DOSE-FXNO	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
DOSE-FXNO	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END>
None	fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with 150 cGy fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	hours of start of chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy )
None	chemotherapy 180 cGy x <RT_Fraction_Number-START> 22 <RT_Fraction_Number-END> with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
DOSE-FXNO	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy ) over 4 days on
None	cm margin to GTV then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
DOSE-FXNO	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	then 180 cGy x <RT_Fraction_Number-START> 6 <RT_Fraction_Number-END> with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
DOSE-FXNO	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
DOSE-FXNO	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
DOSE-FXNO	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice
None	12 Gy ) 2 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
DOSE-FXNO	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
DOSE-FXNO	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	) x <RT_Fraction_Number-START> 8 <RT_Fraction_Number-END> fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
DOSE-FXNO	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose :
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5
None	final 600 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
DOSE-FXNO	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
DOSE-FXNO	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
DOSE-FXNO	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , given over
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
DOSE-FXNO	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
DOSE-FXNO	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
DOSE-FXNO	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
DOSE-FXNO	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
DOSE-FXNO	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to 70 Gy )
None	rets ) 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
DOSE-FXNO	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
DOSE-FXNO	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
DOSE-FXNO	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END>
None	1.8 or 2.25 Gy fractions x <RT_Fraction_Number-START> 20 <RT_Fraction_Number-END> or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
DOSE-FXNO	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
DOSE-FXNO	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ,
None	, including information about boost radiation therapy 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
DOSE-FXNO	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for
None	boost radiation therapy 2 Gy fractions x <RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
DOSE-FXNO	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of
None	<RT_Fraction_Number-START> 35 <RT_Fraction_Number-END> fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
DOSE-FXNO	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END>
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
DOSE-FXNO	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45
None	1 to 3 , 7 to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
DOSE-FXNO	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	to 9 2 Gy fractions once per day x <RT_Fraction_Number-START> 15 <RT_Fraction_Number-END> fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
DOSE-FXNO	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
DOSE-FXNO	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy
None	x <RT_Fraction_Number-START> 60 to 64 <RT_Fraction_Number-END> fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
DOSE-FXNO	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	64 fractions 1.8 Gy fractions x <RT_Fraction_Number-START> 12 <RT_Fraction_Number-END> fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
DOSE-FXNO	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	x <RT_Fraction_Number-START> 23 to 25 <RT_Fraction_Number-END> fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
DOSE-FXNO	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	180 cGy in <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
DOSE-FXNO	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66
None	Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
DOSE-FXNO	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	fractions x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
DOSE-FXNO	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total
None	fractions once per day x <RT_Fraction_Number-START> 25 <RT_Fraction_Number-END> fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
DOSE-FXNO	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
DOSE-FXNO	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
DOSE-FXNO	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given
None	of 59.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
DOSE-FXNO	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
DOSE-FXNO	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
DOSE-FXNO	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	Gy per day x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
DOSE-FXNO	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
DOSE-FXNO	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	x <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
DOSE-FXNO	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	1.5 Gy fractions x <RT_Fraction_Number-START> 16 <RT_Fraction_Number-END> fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
DOSE-FXNO	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
DOSE-FXNO	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
DOSE-FXNO	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	was 54 Gy in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	in <RT_Fraction_Number-START> 28 <RT_Fraction_Number-END> fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
DOSE-FXNO	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
DOSE-FXNO	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	, for a total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	total dose of 5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	5580 cGy 36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	36 Gy in <RT_Fraction_Number-START> 18 <RT_Fraction_Number-END> fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
DOSE-FXNO	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
DOSE-FXNO	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in <RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	<RT_Fraction_Number-START> 10 <RT_Fraction_Number-END> fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in <RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
DOSE-FXNO	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	<RT_Fraction_Number-START> 4 <RT_Fraction_Number-END> fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
DOSE-FXNO	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	Gy once per day Monday through Friday for a total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	total of <RT_Fraction_Number-START> 23 to 28 <RT_Fraction_Number-END> fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
DOSE-FXNO	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
DOSE-FXNO	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in <RT_Fraction_Number-START> 30 to 33 <RT_Fraction_Number-END> fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
DOSE-FXNO	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x <RT_Fraction_Number-START> 33 <RT_Fraction_Number-END> fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
DOSE-SITE	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to <Anatomical_site-START> point A <Anatomical_site-END> given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6
None	of 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6
None	of 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6
None	of 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-SITE	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6
None	of 30 Gy to <Anatomical_site-START> point A <Anatomical_site-END> given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
DOSE-SITE	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
DOSE-SITE	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	50.4 Gy is limited to the <Anatomical_site-START> tumor bed <Anatomical_site-END> . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
DOSE-SITE	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	fractions x 25 fractions , then a 5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	5.4 Gy final <Anatomical_site-START> boost <Anatomical_site-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	hours of start of chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	chemotherapy 180 cGy x 22 with <Anatomical_site-START> 3 cm margin to GTV <Anatomical_site-END> then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	cm margin to GTV then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	then 180 cGy x 6 with <Anatomical_site-START> 2 cm margin to GTV <Anatomical_site-END> , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 172 cGy (
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
DOSE-SITE	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-SITE	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-SITE	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-SITE	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
DOSE-SITE	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
DOSE-SITE	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
DOSE-SITE	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
DOSE-SITE	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
DOSE-SITE	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	<Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . <Anatomical_site-START> Gross tumor volume <Anatomical_site-END> ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( <Anatomical_site-START> GTV <Anatomical_site-END>
DOSE-SITE	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
DOSE-SITE	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
DOSE-SITE	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . <Anatomical_site-START> Gross tumor volume <Anatomical_site-END> ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( <Anatomical_site-START> GTV <Anatomical_site-END> ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was <Anatomical_site-START> all known disease <Anatomical_site-END> including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging <Anatomical_site-START> proven nodal disease <Anatomical_site-END> . The primary planning
DOSE-SITE	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
DOSE-SITE	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
DOSE-SITE	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . <Anatomical_site-START> Gross tumor volume <Anatomical_site-END> ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( <Anatomical_site-START> GTV <Anatomical_site-END> ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was <Anatomical_site-START> all known disease <Anatomical_site-END> including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging <Anatomical_site-START> proven nodal disease <Anatomical_site-END> . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The <Anatomical_site-START> primary planning target volume <Anatomical_site-END> ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( <Anatomical_site-START> PTV1 <Anatomical_site-END> ) included
DOSE-SITE	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
DOSE-SITE	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
DOSE-SITE	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . <Anatomical_site-START> Gross tumor volume <Anatomical_site-END> ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( <Anatomical_site-START> GTV <Anatomical_site-END> ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was <Anatomical_site-START> all known disease <Anatomical_site-END> including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging <Anatomical_site-START> proven nodal disease <Anatomical_site-END> . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The <Anatomical_site-START> primary planning target volume <Anatomical_site-END> ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( <Anatomical_site-START> PTV1 <Anatomical_site-END> ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the <Anatomical_site-START> GTV <Anatomical_site-END> with 2 - to
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . <Anatomical_site-START> Gross tumor volume <Anatomical_site-END> ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( <Anatomical_site-START> GTV <Anatomical_site-END> ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was <Anatomical_site-START> all known disease <Anatomical_site-END> including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging <Anatomical_site-START> proven nodal disease <Anatomical_site-END> . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The <Anatomical_site-START> primary planning target volume <Anatomical_site-END> ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( <Anatomical_site-START> PTV1 <Anatomical_site-END> ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the <Anatomical_site-START> GTV <Anatomical_site-END> with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with <Anatomical_site-START> 2 - to 3-cm margins <Anatomical_site-END> in all
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : <Anatomical_site-START> pelvis <Anatomical_site-END> : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; <Anatomical_site-START> whole bladder <Anatomical_site-END> : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; <Anatomical_site-START> bladder tumor volume <Anatomical_site-END> 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . <Anatomical_site-START> Gross tumor volume <Anatomical_site-END> ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( <Anatomical_site-START> GTV <Anatomical_site-END> ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was <Anatomical_site-START> all known disease <Anatomical_site-END> including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging <Anatomical_site-START> proven nodal disease <Anatomical_site-END> . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The <Anatomical_site-START> primary planning target volume <Anatomical_site-END> ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( <Anatomical_site-START> PTV1 <Anatomical_site-END> ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the <Anatomical_site-START> GTV <Anatomical_site-END> with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with <Anatomical_site-START> 2 - to 3-cm margins <Anatomical_site-END> in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as <Anatomical_site-START> potential nodal involvement <Anatomical_site-END> . Secondary
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with <Anatomical_site-START> 1 - to 1.5-cm margins <Anatomical_site-END> on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including <Anatomical_site-START> proven nodal involvement <Anatomical_site-END> . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
DOSE-SITE	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . <Anatomical_site-START> Tertiary planning treatment volume <Anatomical_site-END> ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
DOSE-SITE	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( <Anatomical_site-START> PTV3 <Anatomical_site-END> ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
DOSE-SITE	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the <Anatomical_site-START> GTV adjacent to the vascular structures <Anatomical_site-END> specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
DOSE-SITE	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a <Anatomical_site-START> 0.5-cm margin <Anatomical_site-END> . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
DOSE-SITE	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to <Anatomical_site-START> PTV3 <Anatomical_site-END> was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36
DOSE-SITE	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. <Anatomical_site-START> Tertiary planning treatment volume <Anatomical_site-END> ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( <Anatomical_site-START> PTV3 <Anatomical_site-END> ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the <Anatomical_site-START> GTV adjacent to the vascular structures <Anatomical_site-END> specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a <Anatomical_site-START> 0.5-cm margin <Anatomical_site-END> . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to <Anatomical_site-START> PTV3 <Anatomical_site-END> was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
DOSE-SITE	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	<Anatomical_site-START> Tertiary planning treatment volume <Anatomical_site-END> ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( <Anatomical_site-START> PTV3 <Anatomical_site-END> ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the <Anatomical_site-START> GTV adjacent to the vascular structures <Anatomical_site-END> specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a <Anatomical_site-START> 0.5-cm margin <Anatomical_site-END> . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to <Anatomical_site-START> PTV3 <Anatomical_site-END> was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the <Anatomical_site-START> GTV adjacent to the vascular structures <Anatomical_site-END> specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a <Anatomical_site-START> 0.5-cm margin <Anatomical_site-END> . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to <Anatomical_site-START> PTV3 <Anatomical_site-END> was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
DOSE-SITE	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
DOSE-SITE	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a <Anatomical_site-START> 0.5-cm margin <Anatomical_site-END> . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to <Anatomical_site-START> PTV3 <Anatomical_site-END> was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
DOSE-SITE	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	was 54 Gy in 28 fractions . Synchronously , <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	in 28 fractions . Synchronously , <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	, <Anatomical_site-START> PTV1 <Anatomical_site-END> and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and <Anatomical_site-START> PTV2 <Anatomical_site-END> received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ;
None	and 50.4 Gy , respectively . 4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
DOSE-SITE	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
DOSE-SITE	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total
None	4500 cGy is administered to the <Anatomical_site-START> tumor volume <Anatomical_site-END> plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a <Anatomical_site-START> 3 cm margin <Anatomical_site-END> , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END>
None	margin , followed by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2
None	by 1080 cGy to only the <Anatomical_site-START> preradiation tumor volume <Anatomical_site-END> , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END>
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
DOSE-SITE	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Anatomical_site-START> boost <Anatomical_site-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to <Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
DOSE-SITE	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	<Anatomical_site-START> involved fields <Anatomical_site-END> 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
DOSE-SITE	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
DOSE-SITE	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
DOSE-SITE	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	1.8 Gy fractions to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after
None	to the initial <Anatomical_site-START> tumor volume <Anatomical_site-END> ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician
None	55.8 Gy was administered to original <Anatomical_site-START> bony tumors <Anatomical_site-END> and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	postinduction chemotherapy <Anatomical_site-START> soft tissue volumes <Anatomical_site-END> plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	tissue volumes plus a <Anatomical_site-START> 2 cm margin <Anatomical_site-END> to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
DOSE-SITE	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	specified ) 40.8 Gy ; total induction dose to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	to <Anatomical_site-START> regional lymph nodes <Anatomical_site-END> given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
DOSE-SITE	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
DOSE-SITE	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
DOSE-SITE	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
DOSE-SITE	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Anatomical_site-START> boost <Anatomical_site-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the <Anatomical_site-START> tumor bed <Anatomical_site-END> 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the <Anatomical_site-START> involved field <Anatomical_site-END> 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
